Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease Read more about Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
Lantheus Medical Imaging Announces Expiration of Consent Solicitation and Receipt of Requisite Consents Read more about Lantheus Medical Imaging Announces Expiration of Consent Solicitation and Receipt of Requisite Consents
Lantheus Medical Imaging Announces Proposed Private Offering of $150 Million of Senior Unsecured Notes Read more about Lantheus Medical Imaging Announces Proposed Private Offering of $150 Million of Senior Unsecured Notes
Lantheus Medical Imaging Commences Exchange Offer Read more about Lantheus Medical Imaging Commences Exchange Offer
Lantheus Medical Imaging Announces FDA Accepts for Review DEFINITY® Supplemental New Drug Application for Use in Stress Echocardiography Read more about Lantheus Medical Imaging Announces FDA Accepts for Review DEFINITY® Supplemental New Drug Application for Use in Stress Echocardiography
Lantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99 Read more about Lantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99
Lantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada Read more about Lantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada
Lantheus Medical Imaging, Inc. to Present Clinical Data on Investigational Cardiac PET Imaging Agents at American Society of Nuclear Cardiology Read more about Lantheus Medical Imaging, Inc. to Present Clinical Data on Investigational Cardiac PET Imaging Agents at American Society of Nuclear Cardiology
Lantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents Read more about Lantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents
Lantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India Read more about Lantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India
